Search

Search Constraints

You searched for: Author/Creator Adams, Sylvia

Search Results

21. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer. Issue 8 (13th August 2021)

22. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice. Issue 5 (9th April 2020)

23. Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome. (7th November 2013)

24. TP012/#1420 XMT-1660: a phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers. (4th December 2022)

25. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. (October 2018)

26. Voxelwise analysis of simultaneously acquired and spatially correlated 18F‐fluorodeoxyglucose (FDG)‐PET and intravoxel incoherent motion metrics in breast cancer. Issue 3 (25th October 2016)